CLINICAL_TRIALS
trial_result
· 2019-09-30
Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers [Phase 1]
Summary
Phase 1 pharmacokinetics and safety study of emicizumab in healthy Chinese volunteers completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Healthy Volunteers, Hemophilia A | Phase 1 | Status: COMPLETED | Results posted: 2019-09-30